Arrowhead Pharmaceuticals Inc (ARWR) Ownership

18.54 ↑0.26 (1.42%)

As of December 31, 1969, 7:00pm EST.

Institutions
Mutual Funds

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Arrowhead Pharmaceuticals Inc (ARWR), owning a total of 15.7 million shares. Combined, the top 44 institutional holders of ARWR own 90.56% of the company with a total of 110.7 million shares.

In the latest ownership report on June 30th 2024, the top 44 institutional holders increased their combined ownership of ARWR by 4.8 million shares. 14 institutions bought 6,289,798 total additional shares and increased their ownership by an average of 64.42%. However 4 institutions sold 1,524,412 total shares and decreased their ownership by an average of 12.07%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Arrowhead Pharmaceuticals increased by a net total of 4,765,386 in the latest quarter.

Institution Ownership Chart

Latest Institutional Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	12.616%	2.193%	15,683,206	336,569	2024-06-30
Vanguard Group Inc	9.825%	-1.531%	12,214,101	-189,949	2024-06-30
venBio Select Advisor LLC	7.150%	3.896%	8,888,888	333,333	2024-06-30
FMR Inc	5.480%	6.531%	6,812,233	417,605	2024-06-30
State Street Corp	4.696%	-11.019%	5,837,762	-722,941	2024-06-30
Slate Path Capital LP	3.329%	0.000%	4,139,000	0	2024-06-30
Morgan Stanley - Brokerage Accounts	2.920%	59.814%	3,630,556	1,358,822	2024-06-30
Artal Group S A	2.566%	5.029%	3,189,389	152,721	2024-06-30
Geode Capital Management, LLC	2.363%	6.655%	2,937,948	183,314	2024-06-30
T. Rowe Price Investment Management,Inc.	2.060%	45.594%	2,560,833	801,950	2024-06-30
JPMorgan Chase & Co	1.863%	-12.220%	2,315,705	-322,358	2024-06-30
UBS Asset Mgmt Americas Inc	1.842%	145.225%	2,290,154	1,356,254	2024-06-30
NORGES BANK	1.275%	19.925%	1,585,320	263,393	2024-06-30
Northern Trust Corp	1.064%	1.697%	1,322,718	22,069	2024-06-30
Goldman Sachs Group Inc	1.016%	20.381%	1,263,442	213,903	2024-06-30
Bank of New York Mellon Corp	0.873%	2.852%	1,085,069	30,086	2024-06-30
Charles Schwab Investment Management Inc	0.800%	1.078%	994,361	10,606	2024-06-30
Citadel Advisors Llc	0.763%	581.006%	948,444	809,173	2024-06-30
Rokos Capital Management LLP	0.756%	-23.526%	939,984	-289,164	2024-06-30
Aquilo Capital Management, LLC	0.731%	0.000%	908,474	0	2024-06-30

Top Institutions

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
BlackRock Inc	12.616%	2.193%	15,683,206	336,569	2024-06-30
Vanguard Group Inc	9.825%	-1.531%	12,214,101	-189,949	2024-06-30
venBio Select Advisor LLC	7.150%	3.896%	8,888,888	333,333	2024-06-30
FMR Inc	5.480%	6.531%	6,812,233	417,605	2024-06-30
State Street Corporation	5.278%	-3.874%	6,560,703	-264,408	2024-03-31
State Street Corp	4.696%	-11.019%	5,837,762	-722,941	2024-06-30
Slate Path Capital LP	3.329%	0.000%	4,139,000	0	2024-06-30
Morgan Stanley - Brokerage Accounts	2.920%	59.814%	3,630,556	1,358,822	2024-06-30
Artal Group S A	2.566%	5.029%	3,189,389	152,721	2024-06-30
Geode Capital Management, LLC	2.363%	6.655%	2,937,948	183,314	2024-06-30
AllianceBernstein L.P.	2.418%	4.768%	2,584,693	117,633	2022-12-31
T. Rowe Price Investment Management,Inc.	2.060%	45.594%	2,560,833	801,950	2024-06-30
JPMorgan Chase & Co	1.863%	-12.220%	2,315,705	-322,358	2024-06-30
Amvescap Plc.	1.862%	-5.597%	2,306,308	-136,730	2023-12-31
UBS Asset Mgmt Americas Inc	1.842%	145.225%	2,290,154	1,356,254	2024-06-30
Credit Suisse First Boston (CSFB)	1.308%	-6.808%	1,626,513	-118,829	2024-03-31
NORGES BANK	1.275%	19.925%	1,585,320	263,393	2024-06-30
Northern Trust Corp	1.064%	1.697%	1,322,718	22,069	2024-06-30
Capital Research & Mgmt Co - Division 3	1.031%	55.246%	1,277,560	454,631	2023-12-31
Goldman Sachs Group Inc	1.016%	20.381%	1,263,442	213,903	2024-06-30
Pictet Asset Manangement SA	0.987%	10,418.100%	1,225,987	1,214,331	2024-03-31
First Manhattan Company	0.971%	-0.097%	1,105,587	-1,075	2022-09-30
Bank of America Corp	0.892%	189.539%	1,105,172	723,471	2023-09-30
First Manhattan Co. LLC	0.887%	0.000%	1,099,154	0	2023-09-30
Bank of New York Mellon Corp	0.873%	2.852%	1,085,069	30,086	2024-06-30
Fiera Capital Corporation	1.014%	-1.008%	1,083,655	-11,037	2022-12-31
Avidity Partners Management LP	0.859%	15.016%	1,063,897	138,897	2023-09-30
Ameriprise Financial Inc	0.803%	7.398%	997,297	68,697	2024-03-31
Charles Schwab Investment Management Inc	0.800%	1.078%	994,361	10,606	2024-06-30
Millennium Management LLC	0.904%	68.408%	969,394	393,770	2023-03-31
Citadel Advisors Llc	0.763%	581.006%	948,444	809,173	2024-06-30
Rokos Capital Management LLP	0.756%	-23.526%	939,984	-289,164	2024-06-30
Woodline Partners LP	0.748%	97.907%	927,187	458,690	2023-12-31
Aquilo Capital Management, LLC	0.731%	0.000%	908,474	0	2024-06-30
WESTERN FINANCIAL CORPORATION	0.757%	0.000%	820,320	0	2022-09-30
Western Financial Corp	0.757%	0.000%	820,320	0	2022-09-30
Western Financial Corp/CA	0.662%	0.000%	820,239	0	2023-12-31
Nomura Holdings Inc	0.710%	17.181%	761,147	111,599	2023-03-31
Renaissance Technologies Corp	0.708%	71.293%	755,400	314,400	2022-09-30
Nuveen Asset Management, LLC	0.661%	10.118%	700,276	64,342	2022-06-30
Dimensional Fund Advisors, Inc.	0.642%	94.109%	687,911	333,516	2023-09-30
Point72 Asset Management, L.P.	0.625%	68.390%	666,600	270,732	2022-09-30
COMMODORE CAPITAL LP	0.569%	6.087%	610,000	35,000	2023-06-30
HHG PLC	0.523%	-0.584%	565,908	-3,325	2022-12-31

Mutual Fund Ownership

iShares Core S&P Mid-Cap ETF is the biggest individual fund holder of Arrowhead Pharmaceuticals Inc (ARWR), owning a total of 3.9 million shares. Combined, the top 36 mutual fund holders of ARWR own 41.65% of the company with a total of 50.4 million shares.

In the latest ownership report on October 31st 2024, the top 36 fund holders increased their combined ownership of ARWR by 68 thousand shares. 1 funds bought 2,128 total additional shares and increased their ownership by an average of 0.05%. However 5 funds sold 69,636 total shares and decreased their ownership by an average of 1.23%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Arrowhead Pharmaceuticals decreased by a net total of -67,508 in the latest report.

Mutual Funds Chart

Latest Mutual Fund Ownership Changes

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
iShares Core S&P Mid-Cap ETF	3.154%	0.054%	3,920,715	2,128	2024-10-31
iShares Russell 2000 ETF	2.471%	-0.224%	3,071,543	-6,902	2024-10-31
SPDR® S&P Biotech ETF	1.540%	-1.423%	1,914,106	-27,636	2024-10-31
iShares Russell 2000 Growth ETF	0.854%	0.000%	1,061,118	0	2024-10-31
iShares Biotechnology ETF	0.670%	-1.024%	832,887	-8,619	2024-10-31
iShares S&P Mid-Cap 400 Growth ETF	0.622%	-0.049%	772,747	-379	2024-10-31
State St Russell Sm/Mid Cp® Indx NL Cl C	0.589%	-3.441%	732,435	-26,100	2024-10-31

Top Mutual Funds

Owner	Percent Owned	Percent Change	Shares Owned	Share Change	Date Reported
iShares Core S&P Mid-Cap ETF	3.154%	0.054%	3,920,715	2,128	2024-10-31
Vanguard Total Stock Mkt Idx Inv	2.979%	0.108%	3,703,465	3,976	2024-09-30
Vanguard Instl Ttl Stck Mkt Idx Tr	3.000%	5.227%	3,215,729	159,736	2023-03-31
iShares Russell 2000 ETF	2.471%	-0.224%	3,071,543	-6,902	2024-10-31
Vanguard Small Cap Index	2.375%	-1.157%	2,952,870	-34,572	2024-09-30
SPDR® S&P Biotech ETF	1.540%	-1.423%	1,914,106	-27,636	2024-10-31
Vanguard Institutional Extnd Mkt Idx Tr	1.518%	0.437%	1,887,269	8,202	2024-09-30
Invesco Global Opportunities A	1.456%	0.000%	1,803,700	0	2023-12-31
Invesco Global Multi Cap Growth	1.456%	-9.815%	1,803,700	-196,300	2023-12-31
Vanguard Small Cap Growth Index Inv	1.311%	-1.208%	1,630,263	-19,930	2024-09-30
Vanguard Extended Market Index Investor	1.364%	0.318%	1,462,249	4,636	2023-08-31
Fidelity Growth Compy Commingled Pl S	1.040%	6.619%	1,293,038	80,272	2024-09-30
American Funds SMALLCAP World A	1.031%	55.246%	1,277,560	454,631	2023-12-31
Fidelity Small Cap Index	0.983%	-2.415%	1,221,447	-30,230	2024-08-31
Fidelity Growth Compy Commingled Pl O	0.976%	11.790%	1,212,766	127,900	2024-08-31
CS (Lux) Digital Health Equity SB USD	0.966%	0.000%	1,200,000	0	2024-05-31
UBS (Lux) Digital Health Equity SB USD	0.965%	0.000%	1,200,000	0	2024-09-30
T. Rowe Price US Small-Cap Core Equity	0.893%	36.922%	1,109,494	299,184	2024-09-30
T. Rowe Price Small-Cap Stock	0.893%	7.441%	1,109,494	76,843	2024-09-30
iShares Russell 2000 Growth ETF	0.854%	0.000%	1,061,118	0	2024-10-31
SPDR® S&P MIDCAP 400 ETF Trust	0.798%	0.126%	992,175	1,247	2024-09-30
Fidelity® Small Cap Index	0.910%	3.113%	977,823	29,524	2023-10-31
Fidelity Growth Company Fund	0.748%	5.878%	929,869	51,622	2024-09-30
Fidelity Small Cap Growth	0.699%	-0.261%	869,070	-2,274	2024-08-31
Fidelity® Select Biotechnology	0.796%	-18.107%	854,632	-188,965	2023-11-30
iShares Biotechnology ETF	0.670%	-1.024%	832,887	-8,619	2024-10-31
JPMorgan Small Cap Growth A	0.649%	0.000%	807,099	0	2024-09-30
AB Small Cap Growth A	0.722%	-1.728%	781,480	-13,743	2023-02-28
iShares S&P Mid-Cap 400 Growth ETF	0.622%	-0.049%	772,747	-379	2024-10-31
State St Russell Sm/Mid Cp® Indx NL Cl C	0.589%	-3.441%	732,435	-26,100	2024-10-31
Fidelity Extended Market Index	0.576%	2.035%	716,074	14,281	2024-06-30
Fidelity Select Biotechnology	0.574%	0.000%	713,170	0	2024-05-31
Pictet-Biotech P USD	0.531%	-0.979%	659,564	-6,522	2024-03-31
Fidelity VIP Mid Cap Initial	0.530%	0.000%	657,540	0	2024-03-31
Fidelity® Extended Market Index	0.537%	1.125%	577,065	6,421	2023-11-30
State St S&P Midcap® Indx SL Cl II	0.479%	0.000%	514,015	0	2023-11-30